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a  b  s  t  r  a  c  tiarrheal  disease  due  to Group  A rotaviruses  continues  to be  an  important  cause  of  morbidity  in  the  developing  world  and  India  contributes  signiﬁcantly
o the  disease  burden.  Surveillance  carried  out  between  July  2009  and  June  2012  at two  medical  centers  in  south  India  and  one  center  in  north  India
stimated  39% of all  diarrheal  admissions  to  be due  to rotavirus.  The  most  prevalent  genotype  isolated  was  G1P[8](33%)  followed  by  G2P[4](17%).  G9P[4]
as  also  emerged  as  a signiﬁcant  cause  of  rotavirus  diarrhea.  No  seasonal  variation  was  noticed  from  the  centers  in south  India,  whereas  we  observed
ncreased  rotavirus  diarrhea  in  the  center  in  north  India  during  March  and  April.
©  2014  Published  by  Elsevier  Ltd.  This  is  an  open  access  article  under  the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).. Introduction
Group A rotavirus remains one of the leading etiological agents
f infectious diarrhea in children <5 years of age, in developing
ountries. India contributes to 22% of rotavirus diarrhea related
ortality in the world [1]. A previous multi-center study under the
ndian Council of Medical Research (ICMR) and US Centers for Dis-
ase Control and Prevention (CDC) showed that 40% of the diarrheal
dmissions were attributable to rotavirus [2,3].
Two vaccines against rotavirus based on immunogenicity test-
ng, Rotarix and Rotateq, are licensed and available in India [4,5].
hile phase II/III trials for other candidate vaccines are ongoing [6],
t is important to monitor the burden of rotavirus diarrhea in India
o gauge the effectiveness and impact of vaccines, when and where
hey are used, and possibly to monitor the emergence of strains
nder vaccine pressure.
We conducted a multicenter hospital-based surveillance from
uly 2009 to June 2012 to determine the burden and molecular
pidemiology of diarrheal disease due to rotavirus.
. Material and methodsThe Christian Medical College (CMC), Vellore, Child Jesus Hos-
ital (IJH), Trichy, and St. Stephen’s Hospital (SSH), Delhi took part
∗ Corresponding author. Tel.: +91 416 228 2052.
E-mail address: gkang@cmcvellore.ac.in (G. Kang).
ttp://dx.doi.org/10.1016/j.vaccine.2014.03.001
264-410X/© 2014 Published by Elsevier Ltd. This is an open access article under the CC in hospital-based surveillance from July 2009 to June 2012 at CMC
and IJH and July 2009 to June 2011 at SSH, following the previ-
ously described protocol [2]. Brieﬂy, all children <5 years of age,
admitted with a diagnosis of diarrhea were approached for par-
ticipation in this study. After obtaining informed consent, a stool
sample was  collected within 24 h of admission. Stool samples were
shipped to CMC  at 4 ◦C every 15 days. The study was approved by
the institutional review board (IRB) of the participating centers.
2.1. Sample testing
All the stool samples were shipped to the testing laboratory
(CMC) at 4 ◦C. Samples were tested for the presence of rotavirus
using a commercially available antigen detection ELISA (PremierTM
Rotaclone®, Meridian Biosciences) as per kit protocol. Samples
showing an OD value of >0.150 were reported as positive. An inter-
nal control was included in all runs, and the run was repeated if the
internal control did not fall in the expected range.
2.2. Genotyping samples
Genotyping was performed on the antigen positive sam-
ples. RNA was extracted using the QIAamp Viral RNA Mini Kit.
Complementary DNA was  synthesized using random primers
(Pd(N)6 hexamers; Pharmacia Biotech) and 400 units of Moloney
murine leukemia virus reverse transcriptase (Invitrogen Life Tech-
nologies) and was used as template for VP7 and VP4 (G and P) typing
in PCRs using published oligonucleotide primers and protocols to
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Table 1
Genotypes isolated during surveillance of rotavirus gastroenteritis in children less
than 5 years of age hospitalized in India between July 2009 and June 2012.
P4 P6 P8 Other P P untyped Mixed P Total
G1 2 4 133 0 18 10 168
G2  69 0 0 0 3 1 73
G9  43 0 25 0 4 1 73
G12  0 25 14 0 2 0 41
Other G 0 0 0 0 1 0 1
G  untyped 1 1 5 0 9 0 15
G  mixed 9 4 2 0 5 4 24
F
Gig. 1. Seasonal trend of rotavirus positivity at two sites in south India and one site
n  north India. The sites in south India participated from July 2009 to June 2012. The
orth Indian site participated from July 2009 to June 2011.
etect VP7 genotypes G1, G2, G3, G4, G8, G9, G10, and G12 and VP4
enotypes P[4], P[6], P[8], P[9], P[10], and P[11] [2].
Samples which failed to type the ﬁrst time were conﬁrmed to
e rotavirus positive by PCR to detect the VP6 gene. If the VP6 PCR
as positive, alternate primer sets were used to attempt genotyp-
ng. Samples which were VP6 negative were re-extracted by Trizol
ethod and subjected to a repeat VP6 PCR to conﬁrm or rule out
he presence of rotavirus [7].
. Results
A total of 1191 children were recruited from the 3 sites over the
tudy period and rotavirus was detected in 458 children using the
ntigen detection ELISA, accounting for 39% of the cases of diarrhea.
he detection rates of rotavirus varied from 26% in Vellore to 40% in
elhi and 50% in Trichy. The proportion positive each year did not
ary by site, with higher rates in Trichy and lower rates in Vellore in
ach year of surveillance. Of the children recruited, 60% were male,
ith mean age of 10.1 months (+SD 7.4) versus 40% female with an
ig. 2. (a) Samples tested and results obtained from the three sites in India between Ju
enotype distribution of rotaviruses identiﬁed at three sites in India between July 2009 aTotal 124 34 179 0 42 16 395
average age of 11.6 months (+SD 7.6). The median age of rotavirus
positive and negative cases was  10 months. Of the children who
tested positive for rotavirus, 63% were less than 1 year of age, 26%
1–2 years of age and 11% between ages of 2 and 5 years.
Rotavirus was detected throughout the year from the sites in
south India compared to the site in the north India where the rates
of detection where much higher during March–April, as compared
to the other months (Fig. 1).
Of the 458 samples which tested positive by ELISA, genotyping
was attempted for 453 strains (98%). Fifty-eight (13%) of the ELISA
positive samples were negative on genotyping, and when tested for
VP6 gene they were all negative even after re-extraction of samples
by another method (Fig. 2a). Of the 395 samples, 96% were G-typed
and 91% were P-typed. Both G and P type was obtained for 315
(80%) strains. The most prevalent G and P type combinations were
G1P[8] (133/395, 33%), G2P[4] (69/395, 17%) and G9 P[4] (43/395,
11%) (Fig. 2b, Table 1). We  detected G12 strains, in combination
with P[6] and P[8], from both the north and south Indian sites, with
more G12 P[6] strain from north India. Mixed infections were seen
ly 2009 and June 2012 from children hospitalized with acute gastroenteritis. (b)
nd June 2012 from children hospitalized with acute gastroenteritis.
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n 9% (n = 36) of the strains which could be typed, G1 in combination
ith either G9 or G12 were the most common.
. Discussion
This study demonstrates the high prevalence of rotavirus
iarrheal disease related hospitalizations in India. The rates are
omparable to other hospital-based studies across India which
ave demonstrated a similar burden of disease. A recent review
stimated that rotavirus hospitalizations ranged from 19.2% in
ucknow to 49.9% in Manipur [8]. The results from the previous
etwork surveillance conducted from 2005 to 2009 across various
ospital sites in India, showed rotavirus positivity rates ranging
rom 35% in western India to 44% in south India [2,3].
The study showed a 39% isolation of rotavirus both from south
nd north India. In Trichy, 50% of samples tested were positive for
otavirus. There was no deﬁnite seasonal pattern in south India,
here sites have had a stable proportion of rotavirus over 3 years.
n northern India, the rates of detection were higher in the months
f March–April for 2 years of surveillance. This differs from previ-
us studies, which showed an earlier peak in rotavirus diarrhea in
ecember to February in north India [2,3,9].
G1P[8] was the most commonly identiﬁed genotype, which fol-
ows the trend seen during the previous surveillance conducted
rom 2005 to 2009 [2,3]. The continued isolation of G12 strains
hows the establishment of these strains in the Indian population.
9P[4] was the third most common strain to be isolated. This is
n contrast to the previous report, where the isolation of G9P[4]
as occasionally reported and the P[8] strain was the predominant
ssociated P type for G9 strains [2,3]. Other sites within India have
lso reported the increased isolation of G9P[4] strains from their
egions [10,11].
The false positivity rates (13%) obtained by the antigen detection
LISA were high. This is a cause for concern because in prior stud-
es, rates of false positivity with diarrheal samples have been less
han 10%. To differentiate the truly untyped samples from the neg-
tive samples, we repeated extraction and performed PCR to detect
he VP6 gene, by two different methods, and the samples remained
egative. The majority of the samples with negative PCR result were
orderline positive by ELISA. One explanation is the possible degra-
ation of the nucleic acid during transport. Our results indicate the
eed for close monitoring of ELISA results – commercially available
ntigen detection ELISAs being the common method for rotavirus
etection – and inclusion of additional internal controls.
Surveillance to document the rates of rotavirus related diarrhea
nd the strain distribution is important. The World Health Organi-
ation recommends the use of rotavirus vaccines to prevent severe
otavirus gastroenteritis globally [12]. Although vaccine efﬁcacy is
ower in developing countries, the effectiveness of the vaccines in
ecreasing the large public health burden of acute gastroenteritis
upports their use [13]. The indigenous development of vaccines is
[
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expected to decrease the price and increase the uptake, particularly
if vaccines can be included for routine childhood immunization. The
increase in availability and use of rotavirus vaccines in the future
underlines the importance of surveillance networks to investigate
the post-vaccine introduction epidemiology of rotavirus in terms
of disease burden and effect on strain types.
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